泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03347 泰格医药

未开盘 07-21 16:08:06

37.540

-0.660

-1.73%

最高38.900	最低37.000	成交量270.88万
今开38.700	昨收38.200	日振幅4.97%
总市值323.22亿	流通市值46.22亿	总股本8.61亿
成交额1.02亿	换手率2.20%	流通股本1.23亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03347","market":"HK","secType":"STK","nameCN":"泰格医药","latestPrice":37.54,"timestamp":1784621286007,"preClose":38.2,"halted":0,"volume":2708800,"delay":0,"changeRate":-0.01727748691099486,"floatShares":123124800,"shares":861000000,"eps":1.2049565183297393,"marketStatus":"未开盘","change":-0.66,"latestTime":"07-21 16:08:06","open":38.7,"high":38.9,"low":37,"amount":102260954,"amplitude":0.049738,"askPrice":37.54,"askSize":1400,"bidPrice":37.52,"bidSize":1700,"shortable":3,"etf":0,"ttmEps":1.0609294560282296,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784683800000},"marketStatusCode":0,"adr":0,"listingDate":1596729600000,"exchange":"SEHK","adjPreClose":38.2,"dividendRate":0.003878,"openAndCloseTimeList":[[1784597400000,1784606400000],[1784610000000,1784620800000]],"volumeRatio":0.859955,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"300347","market":"SZ","secType":"STK","nameCN":"泰格医药","latestPrice":50.18,"timestamp":1784617200000,"preClose":49.06,"halted":0,"volume":28720100,"delay":0,"premium":"-35.43"}},"requestUrl":"/m/hq/s/03347/wiki","defaultTab":"wiki","newsList":[{"id":"2653201360","title":"乔迁2026年二季度表现，兴全商业模式LOF基金季度涨幅25.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653201360","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653201360?lang=zh_cn&edition=full","pubTime":"2026-07-21 23:54","pubTimestamp":1784649284,"startTime":"0","endTime":"0","summary":"证券之星消息，截止2026年二季度末，基金经理乔迁旗下共管理3只基金，本季度表现最佳的为兴全商业模式LOF，季度净值涨25.33%。期间重仓股调仓次数共有73次，其中盈利次数为42次，胜率为57.53%；翻倍级别收益有2次，翻倍率为2.74%。持有期间的估算收益率为615.76%，持有期间隆基股份在2018年到2020年的年报归属净利润增幅达234.34%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100046112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK1583","BK1141","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653493209","title":"郭锐2026年二季度表现，招商丰盈积极配置混合A基金季度涨幅11.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653493209","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653493209?lang=zh_cn&edition=full","pubTime":"2026-07-21 23:41","pubTimestamp":1784648462,"startTime":"0","endTime":"0","summary":"证券之星消息，截止2026年二季度末，基金经理郭锐旗下共管理12只基金，本季度表现最佳的为招商丰盈积极配置混合A，季度净值涨11.42%。持有期间的估算收益率为358%，持有期间泰格医药在2019年到2021年的年报归属净利润增幅达241.5%。持有期间的估算收益率为-65.71%，持有期间东方雨虹在2022年到2024年的年报营业总收入降幅为10.12%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100045920.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","03347","BK1583","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653209123","title":"张迎军2026年二季度表现，博道嘉瑞混合A基金季度涨幅37.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653209123","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653209123?lang=zh_cn&edition=full","pubTime":"2026-07-21 23:34","pubTimestamp":1784648076,"startTime":"0","endTime":"0","summary":"证券之星消息，截止2026年二季度末，基金经理张迎军旗下共管理8只基金，本季度表现最佳的为博道嘉瑞混合A，季度净值涨37.8%。张迎军在担任博道嘉泰回报混合基金经理的任职期间累计任职回报144.48%，平均年化收益率为14.52%。持有期间的估算收益率为93.07%，持有期间泰格医药在2020年到2021年的年报归属净利润增幅达64.26%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100045831.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","03347","BK1576","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652704290","title":"Norges Bank减持泰格医药(03347.HK)51.49万股 每股作价39.7061港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652704290","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652704290?lang=zh_cn&edition=full","pubTime":"2026-07-20 19:30","pubTimestamp":1784547058,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1141","BK1576","BK1583","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651341039","title":"创新药连续大涨，这次真的不一样了吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2651341039","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651341039?lang=zh_cn&edition=full","pubTime":"2026-07-16 17:05","pubTimestamp":1784192720,"startTime":"0","endTime":"0","summary":"政策上，医保初审通过率创新高，定价机制优化，并建立“医保+商保”双层支付体系；产业上，上半年BD交易总额达1100亿美元，国际竞争力显著提升；资金面上，内外资持续回流。行业正从“讲故事”转向盈利兑现，国金证券认为，2027年有望成为中国创新药海外商业化集中兑现的重要节点。","market":"hk","thumbnail":"https://static.tigerbbs.com/8daedf52c02cecfd417dcbd813afb3fa","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8daedf52c02cecfd417dcbd813afb3fa"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6e7a4338b1034ad785d5025385d8625c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3777107","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759","09966","MEDX","BK1161","06622","06978","09995","06606","159992","06996","00241","IBBQ","02268","02359","02137","03347","09688","01672","01801","02269","06618","09606","BK1574"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2651455805","title":"7月15日泰格医药涨6.57%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651455805","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651455805?lang=zh_cn&edition=full","pubTime":"2026-07-15 16:34","pubTimestamp":1784104451,"startTime":"0","endTime":"0","summary":"证券之星消息，7月15日泰格医药涨6.57%，收盘报51.9元，换手率7.07%，成交量40.03万手，成交额20.72亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共110家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为129.74亿元，最新净值2.002，较上一交易日上涨3.85%，近一年上涨11.19%。中欧医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500031174.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK1583","LU1820825898.SGD","BK1141","300347","159760","BK0174","BK0077","BK0216","03347","LU1146622755.USD","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651517580","title":"7月14日泰格医药涨6.08%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651517580","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651517580?lang=zh_cn&edition=full","pubTime":"2026-07-14 16:30","pubTimestamp":1784017855,"startTime":"0","endTime":"0","summary":"证券之星消息，7月14日泰格医药涨6.08%，收盘报48.7元，换手率4.86%，成交量27.54万手，成交额12.96亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共110家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为129.74亿元，最新净值1.9278，较上一交易日下跌1.21%，近一年上涨7.84%。中欧医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400030847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0077","LU1146622755.USD","300347","BK1583","03347","159760","BK1576","BK0028","BK0216","LU1820825898.SGD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651126691","title":"神爱前2026年二季度表现，平安策略先锋混合基金季度涨幅62.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651126691","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651126691?lang=zh_cn&edition=full","pubTime":"2026-07-14 11:02","pubTimestamp":1783998154,"startTime":"0","endTime":"0","summary":"证券之星消息，截止2026年二季度末，基金经理神爱前管理的平安策略先锋混合季度净值涨62.54%。期间重仓股调仓次数共有138次，其中盈利次数为102次，胜率为73.91%；翻倍级别收益有9次，翻倍率为6.52%。持有期间的估算收益率为91.99%，持有期间中际旭创在2023年到2024年的年报归属净利润增幅达137.93%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400016794.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","03347","BK1141","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651386126","title":"医药外包概念股普涨 凯莱英(06821)升逾4% 机构指CXO反弹有望获业绩支撑","url":"https://stock-news.laohu8.com/highlight/detail?id=2651386126","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651386126?lang=zh_cn&edition=full","pubTime":"2026-07-14 10:51","pubTimestamp":1783997504,"startTime":"0","endTime":"0","summary":"2026年Q2Orforglipron等外企重磅品种获批上市，继续支撑药明康德订单增长。药明康德主动回购也彰显对未来信心，截止2026年6月25日，已回购金额超过10亿元。从6月初至今，CXO板块在业绩和订单的支撑下，率先于创新药反弹。自6月8日至7月10日，CRO指数已反弹21.72%。展望下半年，创新药融资增长将继续支持CXO景气度延续。目前CRO龙头企业药明康德2027年预测PE为17.58X，凯莱英为33.19X。随着中期业绩临近，2季度订单趋势逐步明确，CXO反弹有望获得业绩支撑。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985793","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269","LU0979878070.USD","LU0856984785.SGD","LU0348825331.USD","02359","LU0708995583.HKD","LU2242644610.SGD","03347","LU0051755006.USD","LU0181495838.USD","BK1191","BK1515","LU0823426480.USD","LU0516423174.USD","KURE","09939","BK1576","06127","159938","BK1161","BK0132","LU1794554557.SGD","LU2125910500.SGD","SG9999002463.SGD","LU0417516738.SGD","LU0516422952.EUR","LU1242518857.USD","BK0239","LU0456846285.SGD","BK1583","LU1688375341.USD","LU0327786744.USD","BK1574","LU2045819591.USD","LU1720050803.USD","002821","LU0039217434.USD","LU0516423091.SGD","LU0456827905.SGD","LU0043850808.USD","03759","LU0348735423.USD","BK1521","LU3063872942.SGD","LU1046422090.SGD","CXO","IE00B0JY6N72.USD","06821","LU0516422366.SGD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650388761","title":"泰格医药：截至2026年6月30日回购股份20,963,478股","url":"https://stock-news.laohu8.com/highlight/detail?id=2650388761","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650388761?lang=zh_cn&edition=full","pubTime":"2026-07-10 20:52","pubTimestamp":1783687924,"startTime":"0","endTime":"0","summary":"证券之星消息，泰格医药07月09日在投资者关系平台上答复投资者关心的问题。泰格医药回复：投资者您好，截至2026 年6月30日，公司通过股份回购专用证券账户以集中竞价交易方式回购公司股份20,963,478 股，占公司目前总股本的2.4347%，占公司目前A 股总股本的2.8410%。公司后续将根据市场情况在回购期限内继续实施本次回购计划，并将在回购期间根据相关法律、法规和规范性文件的规定及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000042050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0028","300347","BK1583","BK1141","BK0216","LU1820825898.SGD","LU1146622755.USD","BK0077","03347","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650138877","title":"泰格医药：公司及实际控制人未收到中国证监会进一步立案事项相关通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2650138877","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650138877?lang=zh_cn&edition=full","pubTime":"2026-07-10 20:52","pubTimestamp":1783687924,"startTime":"0","endTime":"0","summary":"证券之星消息，泰格医药07月09日在投资者关系平台上答复投资者关心的问题。截至目前，公司及实际控制人未收到中国证监会进一步立案事项相关通知书。公司后续将根据市场情况在回购期限内继续实施本次回购计划，并将在回购期间根据相关法律、法规和规范性文件的规定及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000042051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0028","LU1820825898.SGD","03347","300347","BK1141","BK0216","BK1576","BK1583","LU1146622755.USD","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649295062","title":"大行评级丨大和：微降泰格医药目标价至44港元，评级升至“买入”","url":"https://stock-news.laohu8.com/highlight/detail?id=2649295062","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649295062?lang=zh_cn&edition=full","pubTime":"2026-07-08 13:32","pubTimestamp":1783488774,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1146622755.USD","LU1820825898.SGD","300347","BK1576","BK1583","03347","BK1141","BK0174","BK0077","BK0028","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649984928","title":"Massachusetts Financial Services Company增持泰格医药(03347)15.9万股 每股作价34.9371港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649984928","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649984928?lang=zh_cn&edition=full","pubTime":"2026-07-07 19:08","pubTimestamp":1783422512,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，7月2日，Massachusetts Financial Services Company增持泰格医药(03347)15.9万股，每股作价34.9371港元，总金额约为555.50万港元。增持后最新持股数目约为871.29万股，最新持股比例为7.08%。本交易涉及其他关联方：Sun Life Financial Inc.、Sun Life of Canada (U.S.) Financial Services Holdings, Inc.。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464261.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","03347","BK0174","BK1141","BK1583","EWH","BK0028","LU1146622755.USD","300347","BK0077","BK1576","LU1820825898.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649627102","title":"泰格医药（300347）披露证券变动月报表，7月6日股价上涨4.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649627102","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649627102?lang=zh_cn&edition=full","pubTime":"2026-07-06 22:20","pubTimestamp":1783347625,"startTime":"0","endTime":"0","summary":"截至2026年7月6日收盘，泰格医药报收于48.9元，较前一交易日上涨4.2%，最新总市值为421.04亿元。该股当日开盘46.21元，最高50.66元，最低46.1元，成交额达13.91亿元，换手率为5.03%。近日，公司披露《H股公告-证券变动月报表》。公告显示，截至2026年6月30日，公司法定注册资本无变动，A股和H股的法定股本分别为737,901,250股和123,124,800股，每股面值人民币1元，总注册资本为861,026,050元。已发行股份中，A股减少20,963,478股，全部转为库存股，H股无变动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600037494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","LU1146622755.USD","BK0028","BK1583","300347","BK0216","BK0174","03347","BK0077","BK1141","BK1576","LU1820825898.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174751089","title":"泰格医药更新6月股份变动月报表，回购逾两千万A股保持股本稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1174751089","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174751089?lang=zh_cn&edition=full","pubTime":"2026-07-06 16:55","pubTimestamp":1783328125,"startTime":"0","endTime":"0","summary":"杭州泰格医药科技股份有限公司于2026年7月6日发布截至2026年6月30日的股份变动月报表，注册股本维持人民币861,026,050元。其中A股法定股本为人民币737,901,250元，H股法定股本为人民币123,124,800元，整体注册股本总额保持不变。根据公告，公司于2026年6月10日至6月25日期间实施了该回购，所回购A股目前被持作库存股并未注销，A股总数仍为737,901,250股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648685159","title":"泰格医药(03347)截至6月底累计回购2096.35万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648685159","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648685159?lang=zh_cn&edition=full","pubTime":"2026-07-02 22:30","pubTimestamp":1783002647,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰格医药(03347)发布公告，截至2026年6月30日，公司通过股份回购专用证券账户以集中竞价交易方式回购公司A股股份2096.35万股，占公司目前总股本的2.4347%，占公司目前A股总股本的2.8410%。最高成交价为42.78元/股，最低成交价为38.22元/股，成交总金额为8.24亿元(不含交易费用)。本次回购符合公司回购股份方案及相关法律法规的要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462620.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0174","BK0028","159982","300347","BK1583","BK1141","BK0216","LU1820825898.SGD","LU1146622755.USD","BK0077","03347","BK1576","399300"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648688819","title":"泰格医药：累计回购公司股份20963478股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648688819","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648688819?lang=zh_cn&edition=full","pubTime":"2026-07-02 20:38","pubTimestamp":1782995880,"startTime":"0","endTime":"0","summary":"证券日报网讯7月2日，泰格医药发布公告称，截至2026年6月30日，公司通过股份回购专用证券账户以集中竞价交易方式回购公司股份20，963，478股，占公司目前总股本的2.4347%，占公司目前A股总股本的2.8410%。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-07-02/doc-inifmrtu4043392.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-07-02/doc-inifmrtu4043392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1583","03347","BK0174","BK0077","300347","LU1820825898.SGD","BK0028","LU1146622755.USD","BK1576","BK0216","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648505031","title":"泰格医药：每10股派1.260000元，股权登记日为7月9日","url":"https://stock-news.laohu8.com/highlight/detail?id=2648505031","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648505031?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:29","pubTimestamp":1782984540,"startTime":"0","endTime":"0","summary":"南财智讯7月2日电，泰格医药发布2025年度权益分派实施公告，以本公告日A股总股本扣减公司回购专户持有股份后的可参与分配股数为基数，向全体股东每10股派发现金股利1.260000元（含税），共计派发现金红利8959.28万元（含税）；本次权益分派股权登记日为2026年7月9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607023791995677.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1146622755.USD","BK0028","BK0174","LU1820825898.SGD","BK1583","BK1576","BK0216","03347","BK1141","300347","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647555738","title":"泰格医药：2026年7月22日将派发股息0.14468港元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647555738","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647555738?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:12","pubTimestamp":1782821520,"startTime":"0","endTime":"0","summary":"南财智讯6月30日电，泰格医药（03347.HK）公告，公司将于2026年7月22日派发截至2025年12月31日止年度的末期股息，每股派发0.14468港元（按每10股1.4468港元折算）。本次股息以港元派发，除净日为2026年6月18日，记录日期为2026年6月26日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606303788557788.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["300347","VIG","BK0174","BK1583","EWH","BK4585","BK0028","BK0077","BK1141","BK4588","BK1576","BK0216","03347","LU1146622755.USD","LU1820825898.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647855304","title":"泰格医药(03347.HK)将于7月22日派发末期股息每10股1.4468港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2647855304","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647855304?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:08","pubTimestamp":1782821288,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["03347","BK1583","BK1576","BK1141"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tigermed.net","stockEarnings":[{"period":"1week","weight":-0.0032},{"period":"1month","weight":0.1978},{"period":"3month","weight":-0.1163},{"period":"6month","weight":-0.2561},{"period":"1year","weight":-0.2546},{"period":"ytd","weight":-0.1134}],"compareEarnings":[{"period":"1week","weight":0.0325},{"period":"1month","weight":0.0505},{"period":"3month","weight":-0.0394},{"period":"6month","weight":-0.0562},{"period":"1year","weight":0.0055},{"period":"ytd","weight":-0.0194}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"杭州泰格医药科技股份有限公司是一家主要从事为新药研发提供临床试验全过程专业服务的中国公司。该公司提供服务主要包括临床试验技术服务和临床试验相关及实验室服务。临床试验技术服务提供创新药物、仿制药及医疗器械临床试验运营服务以及与临床试验直接相关的配套服务，包括临床运营、临床药理、注册与法规事务、科学事务等服务。临床试验相关及实验室服务提供在药物开发过程中的相关及实验室服务，包括数据管理及统计分析、临床试验现场管理、受试者招募、医学影像以及实验室等服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.032258},{"month":2,"riseRate":0.5,"avgChangeRate":0.003409},{"month":3,"riseRate":0.5,"avgChangeRate":-0.032695},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.051086},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.017912},{"month":6,"riseRate":0.666667,"avgChangeRate":0.042051},{"month":7,"riseRate":0.666667,"avgChangeRate":0.079598},{"month":8,"riseRate":0,"avgChangeRate":-0.091856},{"month":9,"riseRate":0.333333,"avgChangeRate":0.032062},{"month":10,"riseRate":0.5,"avgChangeRate":-0.025938},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.001369},{"month":12,"riseRate":0.5,"avgChangeRate":0.041242}],"exchange":"SEHK","name":"泰格医药","nameEN":"TIGERMED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰格医药(03347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰格医药,03347,泰格医药股票,泰格医药股票老虎,泰格医药股票老虎国际,泰格医药行情,泰格医药股票行情,泰格医药股价,泰格医药股市,泰格医药股票价格,泰格医药股票交易,泰格医药股票购买,泰格医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰格医药(03347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}